Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

Autor: Groot, S. de, Charehbili, A., Laarhoven, H.W.M. van, Mooyaart, A.L., Dekker-Ensink, N.G., Ven, S. van de, Janssen, L.G.M., Swen, J.J., Smit, V.T.H.B.M., Heijns, J.B., Kessels, L.W., Straaten, T. van der, Bohringer, S., Gelderblom, H., Hoeven, J.J.M. van der, Guchelaar, H.J., Pijl, H., Kroep, J.R., Dutch Breast Canc Res Grp

Publikováno v: Breast Cancer Research, 18, 3
Breast Cancer Research, 18, 1, pp. 3
Breast Cancer Research : BCR
Breast Cancer Research, 18
Breast cancer research, 18(1). BioMed Central

Contains fulltext : 165680.pdf (Publisher’s version ) (Open Access) BACKGROUND: The insulin-like growth factor 1 (IGF-1) pathway is involved in cell growth and proliferation and is associated with tumorigenesis and therapy resistance. This study ai

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3eafc4f912277b720127dc80c392b0d
http://hdl.handle.net/2066/165680

290P - Clinical and Morphological Characteristics of P53-Positive Breast Cancer Stage I in Russian and Dutch Populations

Autor: Kolyadina, I.V., Kuppen, P.J.K., van de Velde, C., Dekker-Ensink, N.G., Bastiaannet, E., Prinse, B., Engels, C., Karseladze, A., Poddubnaya, I.V., Ermilova, V., Komov, D., Frank, G.

Publikováno v: In Annals of Oncology September 2014 25 Supplement 4:iv97-iv97

Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells.

Autor: Dadabayev, A.R., Sandel, M.H., Menon, A.G., Morreau, H., Melief, C.J.M., Offringa, R., van der Burg, S.H., Janssen-van. Rhijn, C., Ensink, N.G., Tollenaar, R.A.E.M., van de Velde, C.J.H., Kuppen, P.J.K.

Publikováno v: Cancer Immunology, Immunotherapy; Nov2004, Vol. 53 Issue 11, p978-986, 9p